Anti-HIV therapy during pregnancy: risk-benefit ratio
- PMID: 11029146
- DOI: 10.1002/1096-9926(200011)62:5<288::AID-TERA2>3.0.CO;2-9
Anti-HIV therapy during pregnancy: risk-benefit ratio
Comment on
-
Developmental toxicity of the HIV-protease inhibitor indinavir in rats.Teratology. 2000 Nov;62(5):291-300. doi: 10.1002/1096-9926(200011)62:5<291::AID-TERA3>3.0.CO;2-A. Teratology. 2000. PMID: 11029147
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical